PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects mutant p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also developing Wild-type p53 or other p53 mutations, including R273H, R273C, R175H, G245S, R248Q, and R282W, as well as other p53 hotspot mutations. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Cranbury, New Jersey.
PMV Pharmaceuticals, Inc. Frequently Asked Questions
What is the ticker symbol for PMV Pharmaceuticals, Inc.? What does PMVP stand for in stocks?
PMVP is the stock ticker symbol of PMV Pharmaceuticals, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.
What is the market capital of PMV Pharmaceuticals, Inc. (PMVP)?
As of Tue Oct 29 2024, market cap of PMV Pharmaceuticals, Inc. is 84.49 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.
What is the fair value of PMVP stock?
You can check PMVP's fair value in chart for subscribers.
Is PMV Pharmaceuticals, Inc. a good stock to buy?
The fair value guage provides a quick view whether PMVP is over valued or under valued. Whether PMV Pharmaceuticals, Inc. is cheap or expensive depends on the assumptions which impact PMV Pharmaceuticals, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for PMVP.